SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Top 10 Most Recent Blog Posts
Market Indices Performance Analysis - May 10, 2024
Category: Markets Total Views: 57By : Editor Updated: 05-10-2024
Today's Stock Market Performance: A Detailed Recap - May 10, 2024
Category: Markets Total Views: 64By : Editor Updated: 05-10-2024
Cryptocurrency Craze: Is It Too Late to Invest or Just the Beginning?
Category: Markets Total Views: 204By : Editor Updated: 05-10-2024
Wall Street to Main Street: Economic Indicators Impacting Your Life 2024
Category: Economy Total Views: 152By : Editor Updated: 05-09-2024
5 Essential Stock Market Investment Tips for Beginners in 2024
Category: Investing Total Views: 189By : Editor Updated: 05-09-2024
Stock Market Outlook for May 10, 2024: Key Factors and Considerations
Category: Markets Total Views: 152By : Editor Updated: 05-09-2024
Sezzle Inc. (SEZL): Stock Analysis Amidst a Surging Stock Price
Category: Stocks Total Views: 218By : Editor Updated: 05-10-2024
Real Estate Sector Update: May 9, 2024
Category: Real Estate Total Views: 162By : Editor Updated: 05-09-2024
Today's Stock Market Performance: A Recap and Overview - May 9, 2024
Category: Markets Total Views: 178By : Editor Updated: 05-09-2024
Trust in Growth: The Future of Australian REITs
Category: Investing Total Views: 304By : Editor Updated: 05-09-2024